Work

Abstract B116: Robust efficacy and favorable safety profile of pan-TEAD inhibitors in oncogenic Hippo pathway-dysregulated cancers including mesothelioma

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-b116

Authors: Jisook Kim, Chunghoon Shin, Jisu Yun, Youngkyo Jeon, Suho Kim, Heesun Moon, Hobin Im, Jooyun Byun, Seung Hyun Jung, Young Gil Ahn

Institution: Hanmi Pharmaceutical (South Korea)

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415455879

Cites:

Cited by:

Related to: